Aaron J. Kosar

Array ( [id] => 4948966 [patent_doc_number] => 20080305092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Methods of treating autoimmune disease via CTLA-4IG' [patent_app_type] => utility [patent_app_number] => 12/044679 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 27490 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305092.pdf [firstpage_image] =>[orig_patent_app_number] => 12044679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385185 [patent_doc_number] => 20090226430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/040240 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 22221 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226430.pdf [firstpage_image] =>[orig_patent_app_number] => 12040240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420132 [patent_doc_number] => 20100150915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTRATION OF ALPHA-FETOPROTEIN IN COMBINATION WITH AN INTEGRIN ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/527816 [patent_app_country] => US [patent_app_date] => 2008-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 21239 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150915.pdf [firstpage_image] =>[orig_patent_app_number] => 12527816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813318 [patent_doc_number] => 20080193949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'METHODS FOR DIAGNOSING AND TREATING HEMOSTATIC DISORDERS BY MODULATING P-SELECTIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/030576 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 27906 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193949.pdf [firstpage_image] =>[orig_patent_app_number] => 12030576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5472966 [patent_doc_number] => 20090246132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof' [patent_app_type] => utility [patent_app_number] => 12/068545 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2719 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246132.pdf [firstpage_image] =>[orig_patent_app_number] => 12068545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4898894 [patent_doc_number] => 20080118508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b' [patent_app_type] => utility [patent_app_number] => 12/011058 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9363 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118508.pdf [firstpage_image] =>[orig_patent_app_number] => 12011058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785012 [patent_doc_number] => 20080138341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Anti-CD70 antibody and its use for the treatment of cancer and immune disorders' [patent_app_type] => utility [patent_app_number] => 12/016814 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 28035 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138341.pdf [firstpage_image] =>[orig_patent_app_number] => 12016814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422004 [patent_doc_number] => 20090148459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents' [patent_app_type] => utility [patent_app_number] => 11/971675 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 58476 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148459.pdf [firstpage_image] =>[orig_patent_app_number] => 11971675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10649414 [patent_doc_number] => 09365650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Single chain antibodies that specifically bind to the activated state of the platelet integrin receptor GP IIb/IIIa' [patent_app_type] => utility [patent_app_number] => 13/986452 [patent_app_country] => US [patent_app_date] => 2008-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14509 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13986452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 80655 [patent_doc_number] => 07744885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereof' [patent_app_type] => utility [patent_app_number] => 12/001071 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 49 [patent_no_of_words] => 52110 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/744/07744885.pdf [firstpage_image] =>[orig_patent_app_number] => 12001071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745292 [patent_doc_number] => 20080089894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis' [patent_app_type] => utility [patent_app_number] => 11/999412 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5343 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089894.pdf [firstpage_image] =>[orig_patent_app_number] => 11999412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420375 [patent_doc_number] => 20100150931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'NOVEL RECEPTOR FOR CD40L AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/312708 [patent_app_country] => US [patent_app_date] => 2007-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14855 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150931.pdf [firstpage_image] =>[orig_patent_app_number] => 12312708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720320 [patent_doc_number] => 20080242843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'FUNCTION OF A HAPTOGLOBIN-HAEMOGLOBIN RECEPTOR AND THE USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/943175 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19034 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242843.pdf [firstpage_image] =>[orig_patent_app_number] => 11943175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555102 [patent_doc_number] => 08067002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Humanized anti-factor D antibodies' [patent_app_type] => utility [patent_app_number] => 11/931060 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 17629 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067002.pdf [firstpage_image] =>[orig_patent_app_number] => 11931060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421323 [patent_doc_number] => 08277810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Antagonist anti-CD40 antibodies' [patent_app_type] => utility [patent_app_number] => 11/932472 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 42 [patent_no_of_words] => 145227 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11932472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764629 [patent_doc_number] => 20080175840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Methods for treating angiogenesis related disorders' [patent_app_type] => utility [patent_app_number] => 11/980211 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17754 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175840.pdf [firstpage_image] =>[orig_patent_app_number] => 11980211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353499 [patent_doc_number] => 20100086571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'METHODS TO DECREASE THE RISK OF METABOLIC SYNDROME POST IMMUNIZATION' [patent_app_type] => utility [patent_app_number] => 12/444232 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13508 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086571.pdf [firstpage_image] =>[orig_patent_app_number] => 12444232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718621 [patent_doc_number] => 20080241143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Inhibition of leukocyte adhesion' [patent_app_type] => utility [patent_app_number] => 11/904157 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15580 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241143.pdf [firstpage_image] =>[orig_patent_app_number] => 11904157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 215115 [patent_doc_number] => 07618633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses' [patent_app_type] => utility [patent_app_number] => 11/904295 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 39110 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618633.pdf [firstpage_image] =>[orig_patent_app_number] => 11904295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6453900 [patent_doc_number] => 20100105611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHOD OF TREATING RESPIRATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/440463 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6679 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105611.pdf [firstpage_image] =>[orig_patent_app_number] => 12440463 [rel_patent_id] =>[rel_patent_doc_number] =>)